GlassScriptPhysician profile
David C Gorsulowsky
NPI 1649272832
$26,273.27
in general payments reported to CMS, 2019-2025
37 companies · $3,846 in 2025
The $3,846 reported for 2025 was more than what 88% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,763 · 2020: $1,842 · 2021: $2,953 · 2022: $3,494 · 2023: $8,090 · 2024: $4,286 · 2025: $3,846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Consulting Fee: $3,300 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,806.89 |
| Consulting Fee | $3,300.00 |
| Education | $115.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $6,918.99 | 2019-2025 | Adbry |
| Abbvie INC. | $3,282.13 | 2019-2025 | |
| Janssen Biotech, INC. | $2,374.70 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $1,789.95 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Regeneron Healthcare Solutions, INC. | $1,633.95 | 2019-2025 | Dupixent, Libtayo |
| Organogenesis INC. | $1,401.96 | 2020-2025 | Puraply, Via Matrix, Simplimax |
| Sun Pharmaceutical Industries INC. | $1,294.48 | 2019-2025 | Winlevi, Absorica Ld |
| Novartis Pharmaceuticals Corporation | $1,269.09 | 2019-2025 | |
| Galderma Laboratories, L.P. | $900.81 | 2019-2025 | Nemluvio |
| Pfizer INC. | $743.72 | 2019-2025 | |
| Genzyme Corporation | $652.30 | 2019-2025 | |
| Genentech USA, INC. | $636.96 | 2019-2024 | Actemra, Erivedge |
| Incyte Corporation | $410.97 | 2022-2025 | Opzelura |
| Ucb, INC. | $391.43 | 2019-2025 | Bimzelx |
| Amgen INC. | $340.21 | 2022-2025 | Otezla, Otezla |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gorsulowsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.